The editorial policy of the Food and Drug Law Journal is to record, examine, and discuss the progress of the laws and regulations in the fields of food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco. Coverage of historical developments of laws and regulations, analysis of current and emerging developments, prognoses of future directions, and normative comments on what the law should be, are encouraged. The Journal welcomes articles on all aspects of foods, drugs, and related areas. The Journal is the only forum dedicated to discussion of these areas of the law and it:
- creates better knowledge and understanding of the law and regulations;
- promotes the laws' and regulations' operation and development by such understanding and by stimulating critical and creative thinking; and
- effectuates the laws' and regulations' remedial purposes through such informed knowledge.
Submission of Manuscripts and Deadlines
Manuscripts and editorial correspondence should be directed to the Publications Department, 1155 15th Street, NW, Suite 910, Washington, DC 20005 ; Phone: (202) 371-1420; OR email Judy Rein, Editor: email@example.com. Authors should obtain permission to submit their manuscript for publication consideration from their employer if required. The Journal is not responsible for ensuring that authors obtain the necessary approval to publish.
Submission deadlines for 2017:
Volume 72:1 August 29, published winter 2017
Volume 72:2 Symposium Issue published spring 2017
Volume 72:3 April 3, published summer 2017
Volume 72:4 July 10, published winter 2017
All material, including footnotes, must be double-spaced. The author must prepare a short abstract, approximately 50 to 100 words, on the article. Editorial policy requires all Journal articles to use standard legal citation form as set forth in The Bluebook: A Uniform System of Citation (20th ed., The Harvard Law Review Association, Cambridge, Massachusetts).
Peer Review and Editing
Generally, all articles submitted for publication consideration to the Food and Drug Law Journal are peer reviewed by members of the Journal's Editorial Advisory Board. FDLI reserves the right to edit manuscripts accepted for publication.
Georgetown University Law Center's Student Editorial Board will work with authors to provide copy editing and cite and source checking.
Articles and any other material published in the Journal represent the opinions of the author(s) and should not be construed to reflect the opinions of the Editor-in-Chief, FDLI, or the Editorial Advisory Board Members. All submitted articles are expected to reflect the highest professional standards. Except under unusual circumstances, it is the Journal's policy to publish only original work that has not appeared elsewhere. Manuscripts are accepted for review by the Editor-in-Chief with the understanding that the same work has not been and will not be published elsewhere; that all persons listed as authors have given their approval for the submission of the paper; and that any person cited as a source of personal communication has approved such citation. Written authorization of such citation may be required at the Editor-in-Chief's discretion. If the submitted manuscript is under review elsewhere, the Editor-in-Chief must be informed in writing.
Authors submitting a manuscript do so on the understanding that if it is accepted for publication, the copyright to the article, including the right to reproduce the article in all forms and media, shall be assigned exclusively to the Publisher. Authors of articles accepted for publication must sign a copyright assignment form, sent by the Editor with the acceptance letter, transferring the author's copyright interest to the Publisher. The Publisher will not refuse any reasonable request by the author for permission to reproduce any of his or her contributions to the Journal. In the event that an article has been previously published in any form, it is the author's responsibility to have the appropriate person execute the copyright form. The author must determine whether a prior publisher or educational institution has copyrighted the material and, if so, the author must secure a letter from the copyright holder to FDLI granting permission to reprint the article. Authors are also required to submit a copy of the prior published version for review.
Statement of Interest
Authors who have received remuneration for writing the article, or who are or have been involved as a principal or in a representative capacity with the subject matter of the article must so designate this in the affiliation footnote along with his/her current position. Full disclosure is necessary to provide reviewers and readers with useful information to assess the publication. If the paper was written to fulfill degree or school credit requirements while the author was a student, a statement to that effect must be included.
Editorial Advisory Board
The Editorial Advisory Board meets periodically in Washington, DC to discuss important current subjects within the fields of food, drug, cosmetic, medical devices, and biologics law. The Board's function is to provide policy direction for the editorial activities of the Journal. The specific editorial statements and analyses of the Journal's contents are not attributable to the Editorial Advisory Board, FDLI, or to any individual member or members.